Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease
- PMID: 15650008
- DOI: 10.1096/fj.04-3182fje
Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease
Abstract
This study was designed to explore the possibility that caloric restriction (CR) may benefit Alzheimer's disease (AD) by preventing beta-amyloid (Abeta) neuropathology pivotal to the initiation and progression of the disease. We report that a CR dietary regimen prevents Abeta peptides generation and neuritic plaque deposition in the brain of a mouse model of AD neuropathology through mechanisms associated with promotion of anti-amyloidogenic alpha-secretase activity. Study findings support existing epidemiological evidence indicating that caloric intake may influence risk for AD and raises the possibility that CR may be used in preventative measures aimed at delaying the onset of AD amyloid neuropathology.
Similar articles
-
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.FASEB J. 2004 May;18(7):902-4. doi: 10.1096/fj.03-0978fje. Epub 2004 Mar 19. FASEB J. 2004. PMID: 15033922
-
RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.FASEB J. 2009 Aug;23(8):2639-49. doi: 10.1096/fj.08-126383. Epub 2009 Mar 30. FASEB J. 2009. PMID: 19332646
-
Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.FASEB J. 2005 Dec;19(14):2081-2. doi: 10.1096/fj.05-4359fje. Epub 2005 Sep 26. FASEB J. 2005. PMID: 16186174
-
The molecular pathology of Alzheimer's disease.Neuroimaging Clin N Am. 2012 Feb;22(1):11-22, vii. doi: 10.1016/j.nic.2011.11.003. Neuroimaging Clin N Am. 2012. PMID: 22284730 Review.
-
beta-Secretase, APP and Abeta in Alzheimer's disease.Subcell Biochem. 2005;38:79-103. Subcell Biochem. 2005. PMID: 15709474 Review.
Cited by
-
Metabolic disorder in Alzheimer's disease.Metab Brain Dis. 2021 Jun;36(5):781-813. doi: 10.1007/s11011-021-00673-z. Epub 2021 Feb 27. Metab Brain Dis. 2021. PMID: 33638805 Review.
-
Sirtuins: from metabolic regulation to brain aging.Front Aging Neurosci. 2013 Jul 23;5:36. doi: 10.3389/fnagi.2013.00036. eCollection 2013. Front Aging Neurosci. 2013. PMID: 23888142 Free PMC article.
-
Obesity, leptin, and Alzheimer's disease.Ann N Y Acad Sci. 2011 Dec;1243:15-29. doi: 10.1111/j.1749-6632.2011.06274.x. Ann N Y Acad Sci. 2011. PMID: 22211890 Free PMC article. Review.
-
Peripheral and cognitive benefits of physical exercise in a mouse model of midlife metabolic syndrome.Sci Rep. 2022 Feb 28;12(1):3260. doi: 10.1038/s41598-022-07252-x. Sci Rep. 2022. PMID: 35228593 Free PMC article.
-
Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer's Disease.Front Cell Neurosci. 2021 Sep 22;15:746631. doi: 10.3389/fncel.2021.746631. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34630044 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical